556 - A Multicenter Randomized, Blinded Trial of Weaning Opioids for Neonatal Opioid Withdrawal Syndrome

Abbot Laptook, Women & Infants Hospital of Rhode Island, Providence, RI, United States; Adam Czynski, Connecticut Children's Medical Center, East Greenwich, RI, United States; Rouba A. Chahine, RTI International, Vestavia, AL, United States; Rachel G. Greenberg, Duke Clinical Research Institute, Durham, NC, United States; Brian Smith, Duke University, Durham, NC, United States; Erica L. Oliveira, WIHRI, Providence, RI, United States; Jenna Gabrio, RTI, Livermore, CA, United States; Barry S. Eggleston, RTI International, Mebane, NC, United States; Abhik Das, RTI International, North Potomac, MD, United States; Jeannette Lee, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR, United States; Barry Lester, The Warren Alpert Medical School of Brown University, Providence, RI, United States; Dave Clark, NIH/NICHD, Bethesda, MD, United States; Jessica Snowden, Univ of Tennessee Health Science Center, Memphis, TN, United States; NICHD Neonatal Research Network, National Institute of Child Health and Human Development, Bethesda, MD, United States; ECHO IDeA States Pediatric Clinical Trials Network, n/a, North Bethesda, MD, United States